IV Immunoglobulin for Autoimmune Heparin-Induced Thrombocytopenia.

Shuoyan Ning, Theodore E Warkentin

Abstract readEditorialComment

In one paragraph

Article in Chest, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

Autoimmune Heparin-Induced Thrombocytopenia.Journal of clinical medicine · 2023
Review
Spontaneous heparin-induced thrombocytopaenia with adrenal haemorrhage following orthopaedic surgery: a case report and literature review.BMJ case reports · 2021
Article
Refractory Heparin-Induced Thrombocytopenia in a Patient With Subarachnoid Hemorrhage-A Clinical Conundrum.The Neurohospitalist · 2021
Article
Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST).Neurocritical care · 2021
Article

4 · The record

Corrections and comments

Comment on
IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.2017

5 · Who and what money

Authors and funding

2 authors.

Shuoyan NingDepartment of Medicine (Division of Hematology and Thromboembolism), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

Theodore E WarkentinDepartment of Medicine (Division of Hematology and Thromboembolism), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; McMaster Centre for Transfusion Research, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: twarken@mcmaster.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunoglobulins, IntravenousThrombocytopeniaHumansPlatelet Factor 4Immunoglobulins, IntravenousPlatelet Factor 4

Identifiers

PMID28889872

DOI10.1016/j.chest.2017.05.042

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.